173 related articles for article (PubMed ID: 33073558)
1. Copper-64 labeled nanoparticles for positron emission tomography imaging: a review of the recent literature.
Capriotti G; Varani M; Lauri C; Franchi G; Pizzichini P; Signore A
Q J Nucl Med Mol Imaging; 2020 Dec; 64(4):346-355. PubMed ID: 33073558
[TBL] [Abstract][Full Text] [Related]
2. Hybrid Metal-Phenol Nanoparticles with Polydopamine-like Coating for PET/SPECT/CT Imaging.
Suárez-García S; Esposito TVF; Neufeld-Peters J; Bergamo M; Yang H; Saatchi K; Schaffer P; Häfeli UO; Ruiz-Molina D; Rodríguez-Rodríguez C; Novio F
ACS Appl Mater Interfaces; 2021 Mar; 13(9):10705-10718. PubMed ID: 33635046
[TBL] [Abstract][Full Text] [Related]
3. Copper, PET/CT and prostate cancer: a systematic review of the literature.
Piccardo A; Ugolini M; Righi S; Bottoni G; Cistaro A; Paparo F; Giovanella L; Evangelista L
Q J Nucl Med Mol Imaging; 2020 Dec; 64(4):382-392. PubMed ID: 32900177
[TBL] [Abstract][Full Text] [Related]
4. Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes.
Carlos Dos Santos J; Beijer B; Bauder-Wüst U; Schäfer M; Leotta K; Eder M; Benešová M; Kleist C; Giesel F; Kratochwil C; Kopka K; Haberkorn U; Mier W
J Nucl Med; 2020 Jan; 61(1):70-79. PubMed ID: 31541034
[TBL] [Abstract][Full Text] [Related]
5. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
[TBL] [Abstract][Full Text] [Related]
6. Chelators for copper radionuclides in positron emission tomography radiopharmaceuticals.
Cai Z; Anderson CJ
J Labelled Comp Radiopharm; 2014 Apr; 57(4):224-30. PubMed ID: 24347474
[TBL] [Abstract][Full Text] [Related]
7. Intrinsically copper-64-labeled organic nanoparticles as radiotracers.
Liu TW; MacDonald TD; Shi J; Wilson BC; Zheng G
Angew Chem Int Ed Engl; 2012 Dec; 51(52):13128-31. PubMed ID: 23154923
[TBL] [Abstract][Full Text] [Related]
8. Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.
Wadas TJ; Wong EH; Weisman GR; Anderson CJ
Chem Rev; 2010 May; 110(5):2858-902. PubMed ID: 20415480
[No Abstract] [Full Text] [Related]
9. VPAC1-targeted PET/CT scan: improved molecular imaging for the diagnosis of prostate cancer using a novel cell surface antigen.
Truong H; Gomella LG; Thakur ML; Trabulsi EJ
World J Urol; 2018 May; 36(5):719-726. PubMed ID: 29541892
[TBL] [Abstract][Full Text] [Related]
10.
Liu Q; Qian Y; Li P; Zhang S; Liu J; Sun X; Fulham M; Feng D; Huang G; Lu W; Song S
Theranostics; 2018; 8(3):785-799. PubMed ID: 29344306
[No Abstract] [Full Text] [Related]
11. Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research.
Anderson CJ; Ferdani R
Cancer Biother Radiopharm; 2009 Aug; 24(4):379-93. PubMed ID: 19694573
[TBL] [Abstract][Full Text] [Related]
12. Copper-64 based radiopharmaceuticals for brain tumors and hypoxia imaging.
Pasquali M; Martini P; Shahi A; Jalilian AR; Osso JA; Boschi A
Q J Nucl Med Mol Imaging; 2020 Dec; 64(4):371-381. PubMed ID: 33026209
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles for SPECT and PET Imaging: Towards Personalized Medicine and Theranostics.
Polyak A; Ross TL
Curr Med Chem; 2018; 25(34):4328-4353. PubMed ID: 28875837
[TBL] [Abstract][Full Text] [Related]
14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
15. Copper-64-immunoPET imaging: bench to bedside.
Natarajan A
Q J Nucl Med Mol Imaging; 2020 Dec; 64(4):356-363. PubMed ID: 33045821
[TBL] [Abstract][Full Text] [Related]
16. Single photon emission computed tomography and positron emission tomography in cancer imaging.
Coleman RE
Cancer; 1991 Feb; 67(4 Suppl):1261-70. PubMed ID: 1991287
[TBL] [Abstract][Full Text] [Related]
17. Copper radionuclides and radiopharmaceuticals in nuclear medicine.
Blower PJ; Lewis JS; Zweit J
Nucl Med Biol; 1996 Nov; 23(8):957-80. PubMed ID: 9004284
[TBL] [Abstract][Full Text] [Related]
18.
Karimi Z; Sadeghi M; Mataji-Kojouri N
Appl Radiat Isot; 2018 Jul; 137():56-61. PubMed ID: 29571037
[No Abstract] [Full Text] [Related]
19. Copper chelation chemistry and its role in copper radiopharmaceuticals.
Wadas TJ; Wong EH; Weisman GR; Anderson CJ
Curr Pharm Des; 2007; 13(1):3-16. PubMed ID: 17266585
[TBL] [Abstract][Full Text] [Related]
20. Peptide and pseudo-peptide.
Mirzaei S; Lipp RW
Q J Nucl Med Mol Imaging; 2020 Dec; 64(4):364-370. PubMed ID: 33045822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
